AAA to hear biotech claim against Japanese drugmaker
A US biotech company has filed a claim with the American Arbitration Association against Daiichi Sankyo over the ownership of technology the Japanese group is using in a drug candidate to treat breast cancer.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.